AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

WGCNA combined with machine learning to explore potential biomarkers and treatment strategies for acute liver failure, with experimental validation

Xinyan Wu1Xiaomei Zheng1Gang Ye( )
College of Veterinary Medicine, Sichuan Agricultural University, No. 211 Huimin Road, Wenjiang District, Chengdu 611130, China

1 These authors contributed equally to this work and are joint first authors.

Show Author Information

Abstract

Background and aims

To identify biomarkers to predict acute liver failure and investigate the mechanisms and immune-related pathways linked to its onset and progression.

Methods

We analyzed gene expression differences between patients with acute liver failure (ALF) and controls in the GSE14668 dataset. Clinically relevant modules and key ALF-associated genes were identified using weighted gene co-expression network analysis (WGCNA) in conjunction with differential gene expression (DEG) analysis. Enrichment analysis was carried out and protein–protein interaction networks were constructed to understand the functions and pathways. Six potential diagnostic biomarkers were identified using machine learning algorithms. Diagnostic performance was assessed via column charts and area under the curve calculations. Single-sample gene set enrichment analysis evaluated the relationship between known marker gene sets and potential biomarker expression. We also examined diagnostic biomarker mRNA levels in ALF models in vivo and in vitro. We estimated the relative infiltration levels of 22 immune cell subpopulations in ALF samples, and explored the link between diagnostic biomarkers and infiltrating immune cells.

Result

We found 352 DEGs associated with ALF. WGCNA analysis and intersecting DEGs identified 191 significant ALF-related genes. Machine learning identified HORMAD2, WNT10A, ATP6V1E2, CMBL, ARRDC4, and LPIN2 as potential diagnostic biomarkers. Cell experiments and quantitative real-time polymerase chain reaction supported the therapeutic potential of eriodictyol for ALF. Immune infiltration analysis suggested that plasma cells, CD4 memory resting and activated T cells, macrophages, and neutrophils might play roles in the progression of ALF.

Conclusion

We identified HORMAD2, WNT10A, ATP6V1E2, CMBL, ARRDC4, and LPIN2, as diagnostic biomarkers for ALF and demonstrated the effectiveness of eriodictyol for treating ALF. Immune cell infiltration may play a significant role in the pathogenesis and progression of ALF.

Electronic Supplementary Material

Download File(s)
iliver-3-4-100133_ESM.docx (22 KB)

References

[1]

Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet 2010;376(9736): 190–201. https://doi.org/10.1016/S0140-6736(10)60274-7.

[2]

Dong V, Nanchal R, Karvellas CJ. Pathophysiology of acute liver failure. Nutr Clin Pract 2020;35(1):24–9. https://doi.org/10.1002/ncp.10459.

[3]

Wang Q, Liu L, Zhang S, et al. Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation. Exp Mol Med 2020;52(3):461–72. https://doi.org/10.1038/s12276-020-0387-z.

[4]

Qiu H, Mao D, Tang N, et al. The underlying mechanisms of Jie-Du-Hua-Yu granule for protecting rat liver failure. Drug Des Dev Ther 2019;13:589–600. https://doi.org/10.2147/DDDT.S180969.

[5]

Wu Z, Han M, Chen T, et al. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 2010;30(6):782–94. https://doi.org/10.1111/j.1478-3231.2010.02262.x.

[6]

Wang H, Chen L, Zhang X, et al. Kaempferol protects mice from d-GalN/LPSinduced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway. Biomed Pharmacother 2019;111:468–75. https://doi.org/10.1016/j.biopha.2018.12.105.

[7]

Huang Y, Zheng S, Wang R, et al. CCL5 and related genes might be the potential diagnostic biomarkers for the therapeutic strategies of rheumatoid arthritis. Clin Rheumatol 2019;38(9):2629–35. https://doi.org/10.1007/s10067-019-04533-1.

[8]

Cai W, Li H, Zhang Y, et al. Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis. PeerJ 2020;8: e8390. https://doi.org/10.7717/peerj.8390.

[9]

Miñoza JMA, Rico JA, Zamora PRF, et al. Biomarker discovery for meta-classification of melanoma metastatic progression using transfer learning. Genes 2022;13(12):2303. https://doi.org/10.3390/genes13122303.

[10]

Aldhyani THH, Alshebami AS, Alzahrani MY. Soft clustering for enhancing the diagnosis of chronic diseases over machine learning algorithms. J Healthc Eng 2020;2020:4984967. https://doi.org/10.1155/2020/4984967.

[11]

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 2008;9:559. https://doi.org/10.1186/1471-2105-9-559.

[12]

Horvath S, Zhang B, Carlson M, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A 2006; 103(46):17402–7. https://doi.org/10.1073/pnas.0608396103.

[13]

Chen YC, Guo YF, He H, et al. Integrative analysis of genomics and transcriptome data to identify potential functional genes of BMDs in females. J Bone Miner Res 2016;31(5):1041–9. https://doi.org/10.1002/jbmr.2781.

[14]

Xie G, Meng X, Wang F, et al. Eriodictyol attenuates arsenic trioxide-induced liver injury by activation of Nrf2. Oncotarget 2017;8(40):68668–74. https://doi.org/10.18632/oncotarget.19822.

[15]

Wang Z, Lan Y, Chen M, et al. Eriodictyol, not its glucuronide metabolites, attenuates acetaminophen-induced hepatotoxicity. Mol Pharm 2017;14(9): 2937–51. https://doi.org/10.1021/acs.molpharmaceut.7b00345.

[16]

Wang F, Gong S, Wang T, et al. Soyasaponin Ⅱ protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice. Theranostics 2020;10(6):2714–26. https://doi.org/10.7150/thno.40128.

[17]

Wu X, Zheng X, Wen Q, et al. Swertia cincta Burkill alleviates LPS/D-GalN-induced acute liver failure by modulating apoptosis and oxidative stress signaling pathways. Aging 2023;15(12):5887–916. https://doi.org/10.18632/aging.204848.

[18]

Goikoetxea-Usandizaga N, Serrano-Maciá M, Delgado TC, et al. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals. Hepatology 2022;75(3):550–66. https://doi.org/10.1002/hep.32149.

[19]

You JA, Gong Y, Wu Y, et al. WGCNA, LASSO and SVM algorithm revealed RAC1 correlated M0 macrophage and the risk score to predict the survival of hepatocellular carcinoma patients. Front Genet 2022;12:730920. https://doi.org/10.3389/fgene.2021.730920.

[20]

Long S, Huang X, Chen Z, et al. Automatic detection of hard exudates in color retinal images using dynamic threshold and SVM classification: algorithm development and evaluation. BioMed Res Int 2019;2019:3926930. https://doi.org/10.1155/2019/3926930.

[21]

Aslan Ö, Oktay A, Katuk B, et al. Prediction of malignancy upgrade rate in high-risk breast lesions using an artificial intelligence model: a retrospective study. Diagn Interv Radiol 2023;29(2):260–7. https://doi.org/10.5152/dir.2022.211047.

[22]

Topaloglu F. A hybrid approach based on k-means and SVM algorithms in selection of appropriate risk assessment methods for sectors. PeerJ Comput Sci 2024;10: e2198. https://doi.org/10.7717/peerj-cs.2198.

[23]

Li J, Zhang X, Ren P, et al. Landscape of RNA-binding proteins in diagnostic utility, immune cell infiltration and PANoptosis features of heart failure. Front Genet 2022; 13:1004163. https://doi.org/10.3389/fgene.2022.1004163.

[24]

Li XY, Wang SL, Chen DH, et al. Construction and validation of a m7G-related genebased prognostic model for gastric cancer. Front Oncol 2022;12:861412. https://doi.org/10.3389/fonc.2022.861412.

[25]

Li YR, Meng K, Yang G, et al. Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis. J Gastrointest Oncol 2022;13(3):1188–203. https://doi.org/10.21037/jgo-22-536.

[26]

Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun 2022;13(1):816. https://doi.org/10.1038/s41467-022-28421-6.

[27]

Zhang P, Reue K. Lipin proteins and glycerolipid metabolism: roles at the ER membrane and beyond. Biochim Biophys Acta Biomembr 2017;1859(9 Pt B): 1583–95. https://doi.org/10.1016/j.bbamem.2017.04.007.

[28]

Reue K. The lipin family: mutations and metabolism. Curr Opin Lipidol 2009;20(3): 165–70. https://doi.org/10.1097/MOL.0b013e32832adee5.

[29]

Csaki LS, Dwyer JR, Fong LG, et al. Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling. Prog Lipid Res 2013;52(3):305–16. https://doi.org/10.1016/j.plipres.2013.04.001.

[30]

Reue K, Wang H. Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders. J Lipid Res 2019; 60(4):728–33. https://doi.org/10.1194/jlr.S091769.

[31]

Paulson QX, Hong J, Holcomb VB, et al. Effects of body weight and alcohol consumption on insulin sensitivity. Nutr J 2010;9:14. https://doi.org/10.1186/1475-2891-9-14.

[32]

Yang X, Zou P, Yao J, et al. Proteomic dissection of cell type-specific H2AXinteracting protein complex associated with hepatocellular carcinoma. J Proteome Res 2010;9(3):1402–15. https://doi.org/10.1021/pr900932y.

[33]

Patwari P, Chutkow WA, Cummings K, et al. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem 2009;284(37):24996–5003. https://doi.org/10.1074/jbc.M109.018093.

[34]

Wu X, Liu J, Liu D, et al. Biosynthesis of eriodictyol from tyrosine by Corynebacterium glutamicum. Microb Cell Factories 2022;21(1):86. https://doi.org/10.1186/s12934-022-01815-3.

[35]

Kwon EY, Choi MS. Dietary eriodictyol alleviates adiposity, hepatic steatosis, insulin resistance, and inflammation in diet-induced obese mice. Int J Mol Sci 2019; 20(5):1227. https://doi.org/10.3390/ijms20051227.

[36]

Guan Q, Liu Y, Xia Z, et al. A novel nano-drug delivery system of glycyrrhetinic acid-mediated intracellular breakable brucine for enhanced anti-hepatitis B efficacy. J Biomater Appl 2024;39(2):150–61. https://doi.org/10.1177/08853282241254750.

[37]

Rajendran P, Ammar RB, Al-Saeedi FJ, et al. Kaempferol inhibits Zearalenoneinduced oxidative stress and apoptosis via the PI3K/Akt-mediated Nrf2 signaling pathway: in vitro and in vivo studies. Int J Mol Sci 2020;22(1):217. https://doi.org/10.3390/ijms22010217.

[38]

Yang DQ, Zuo QN, Wang T, et al. Mitochondrial-targeting antioxidant SS-31 suppresses airway inflammation and oxidative stress induced by cigarette smoke. Oxid Med Cell Longev 2021;2021:6644238. https://doi.org/10.1155/2021/6644238.

[39]

Zorova LD, Popkov VA, Plotnikov EY, et al. Mitochondrial membrane potential. Anal Biochem 2018;552:50–9. https://doi.org/10.1016/j.ab.2017.07.009.

[40]

Baeza J, Smallegan MJ, Denu JM. Mechanisms and dynamics of protein acetylation in mitochondria. Trends Biochem Sci 2016;41(3):231–44. https://doi.org/10.1016/j.tibs.2015.12.006.

[41]

Khanam A, Kottilil S. Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics. Front Immunol 2020;11:2013. https://doi.org/10.3389/fimmu.2020.02013.

[42]

Chen P, Wang YY, Chen C, et al. The immunological roles in acute-on-chronic liver failure: an update. Hepatobiliary Pancreat Dis Int 2019;18(5):403–11. https://doi.org/10.1016/j.hbpd.2019.07.003.

[43]

Shen G, Sun S, Huang J, et al. Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int 2020;14(1):47–56. https://doi.org/10.1007/s12072-019-10008-x.

[44]

Dong X, Gong Y, Zeng H, et al. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure. Liver Int 2013;33(10):1517–26. https://doi.org/10.1111/liv.12248.

[45]

Possamai LA, Thursz MR, Wendon JA, et al. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol 2014;61(2):439–45. https://doi.org/10.1016/j.jhep.2014.03.031.

[46]

Yuan M, Yao L, Hu X, et al. Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies. Front Genet 2022;13: 1004912. https://doi.org/10.3389/fgene.2022.1004912.

iLIVER
Article number: 100133
Cite this article:
Wu X, Zheng X, Ye G. WGCNA combined with machine learning to explore potential biomarkers and treatment strategies for acute liver failure, with experimental validation. iLIVER, 2024, 3(4): 100133. https://doi.org/10.1016/j.iliver.2024.100133

87

Views

0

Crossref

1

Scopus

Altmetrics

Received: 26 September 2024
Revised: 30 October 2024
Accepted: 05 November 2024
Published: 13 November 2024
© 2024 The Author(s). Tsinghua University Press.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Return